Collagen IV Antikörper
Kurzübersicht für Collagen IV Antikörper (ABIN7212370)
Target
Alle Collagen IV (COL4) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Mouse Anti-Collagen IV Mouse Monoclonal Antibody (8E5)
-
Spezifität
- The antibody detects endogenous Collagen IV protein.
-
Aufreinigung
- The antibody was affinity-purified from mouse antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthetic Peptide of Collagen IV
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IF 1:50-200,IHC 1:50-300
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- Collagen IV (COL4) (Collagen, Type IV (COL4))
-
Andere Bezeichnung
- Collagen IV
-
Hintergrund
- Collagen alpha-1(IV) chain [Cleaved into: Arresten]COL4A1 (collagen type IV alpha 1 chain) encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. COL4A1 shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in COL4A1 cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants.
-
Molekulargewicht
- 161kD
-
Gen-ID
- 1282
Target
-